»ï¼º¼¿ïº´¿ø Ç÷¾×Á¾¾ç³»°ú The 2nd Precision Oncology International Symposium (The SMC – Gustave Roussy Partnership : Research Cures Cancer) : 2024-02-02
±³À°ÀÏÀÚ : 2024-02-02
±³À°Àå¼Ò : »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø B1Ãþ °´ç
±³À°ÁÖÁ¦ : (¿Â-¿ÀÇÁ º´Çà)The 2nd Precision Oncology International Symposium (The SMC – Gustave Roussy Partnership : Research Cures Cancer)
ÁÖÃÖ±â°ü : »ï¼º¼¿ïº´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : Ç÷¾×Á¾¾ç³»°ú
´ã´çÀÚ : ³ëÀÎÈñ
¿¬¶ôó : 02-2148-9826
À̸ÞÀÏ : lipm.smc@samsung.com
±³À°Á¾·ù : ³»°ú, ÀÇ»çÇÐ
Âü¼®¿¹»óÀÎ : 300¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 70,000¿ø
ºñ°í »çÀüµî·Ï: ¨çÀü¹®ÀÇ 50,000¿ø ¨èÀü°øÀÇ 30,000¿ø ¨é±âŸ 10,000¿ø´çÀϵî·Ï: ¨çÀü¹®ÀÇ 70,000¿ø ¨èÀü°øÀÇ 50,000¿ø ¨é±âŸ 30,000¿ø (¿ÀÇÁ¶óÀÎ ÁøÇà ½Ã, ¡°ÇöÀåµî·Ï¡±)KMA È®ÀÎ¿ë ¾ÆÀ̵ð 0000(¼ýÀÚ) ºñ¹Ð¹øÈ£ 0000(¼ýÀÚ)
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 02¿ù 02ÀÏ »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °´ç 08:50~08:55 Welcome Messages from SMC leadership ¹Ú½Â¿ì(»ï¼º¼¿ïº´¿ø)
±âŸ 02¿ù 02ÀÏ »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °´ç 08:55~09:00 The Partnership between SMC & Gustave Roussy Fabrice BarlesiÀÌ¿ì¿ë(Gustave Roussy»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 02¿ù 02ÀÏ »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °´ç 09:00~09:20 Gustave Roussy: an overview to cure cancer as an institution Fabrice Barlesi(Gustave Roussy)
±³À°½Ã°£ 02¿ù 02ÀÏ »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °´ç 09:20~09:45 Functional precision medicine in GI cancers Alice Boileve(Gustave Roussy)
±³À°½Ã°£ 02¿ù 02ÀÏ »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °´ç 09:45~10:05 Drug development from academia to clinical trials ³²µµÇö(»ï¼º¼¿ïº´¿ø ½Å°æ¿Ü°ú)
Åä·Ð 02¿ù 02ÀÏ »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °´ç 10:05~10:15 Q&A ( )
±³À°½Ã°£ 02¿ù 02ÀÏ »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °´ç 10:15~10:30 Precision Cancer Medicine at SMC ÀÌÁö¿¬(»ï¼º¼¿ïº´¿ø Ç÷¾×Á¾¾ç³»°ú)
±³À°½Ã°£ 02¿ù 02ÀÏ »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °´ç 10:30~10:45 Adoptive T cell therapy for refractory cancer patients: from concept to clinical trials ±è½ÂÅÂ(»ï¼º¼¿ïº´¿ø Ç÷¾×Á¾¾ç³»°ú)
±³À°½Ã°£ 02¿ù 02ÀÏ »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °´ç 10:45~11:00 AI driven drug discovery from bed to benchside ¼¼º¿í(»ï¼º¼¿ïº´¿ø Á¤Çü¿Ü°ú)
Åä·Ð 02¿ù 02ÀÏ »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °´ç 11:00~11:10 Q&A ( )
±³À°½Ã°£ 02¿ù 02ÀÏ »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °´ç 11:10~11:35 Gustave Roussy : Translational projects in immunoradiotherapy Eric Deutsch(University of Paris-Saclay)
±³À°½Ã°£ 02¿ù 02ÀÏ »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °´ç 11:35~11:50 Deep learning-based auto-segmentation of target volume ³ëÀç¸í(»ï¼º¼¿ïº´¿ø ¹æ»ç¼±Á¾¾çÇаú)
±³À°½Ã°£ 02¿ù 02ÀÏ »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °´ç 11:50~12:05 Experience in clinical trials combining Immunotherapy and radiotherapy ¹ÚÈñö(»ï¼º¼¿ïº´¿ø ¹æ»ç¼±Á¾¾çÇаú)
½Ä»ç 02¿ù 02ÀÏ »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °´ç 12:05~13:00 Á¡½É ( )
±³À°½Ã°£ 02¿ù 02ÀÏ »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °´ç 13:00~13:25 From concept to implementation : 15 years of precision medicine program of Gustave Roussy Fabrice André(Gustave Roussy)
±³À°½Ã°£ 02¿ù 02ÀÏ »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °´ç 13:25~13:50 Precision medicine is finally becoming the reality in prostate cancer Karim Fizazi(Gustave Roussy)
±³À°½Ã°£ 02¿ù 02ÀÏ »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °´ç 13:50~14:05 Insights from healthcare big data for sustainable, long-term cancer control È«Á¤¿ë(»ï¼º¼¿ïº´¿ø Ç÷¾×Á¾¾ç³»°ú)
±³À°½Ã°£ 02¿ù 02ÀÏ »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °´ç 14:05~14:20 Spatiotemporally Resolved Single-cell Analyses Delineate Early Esophageal Squamous Carcinogenesis ¹Îº´ÈÆ(»ï¼º¼¿ïº´¿ø ¼Òȱ⳻°úºÐ°ú)
ÈÞ½Ä 02¿ù 02ÀÏ »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °´ç 14:20~14:40 Q&A / Coffee Break ( )
±³À°½Ã°£ 02¿ù 02ÀÏ »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °´ç 14:40~14:55 Application of 3D Printing-Assisted Tumor Microenvironment in Translational Oncology Çü¼öÁø(»ï¼º¼¿ïº´¿ø Á¤¹ÐÀÇÇÐÇõ½Å¿¬±¸¼Ò)
±³À°½Ã°£ 02¿ù 02ÀÏ »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °´ç 14:55~15:10 Innovations in liver surgery and the potential role of surgeons on precision medicine À¯Áø¼ö(»ï¼º¼¿ïº´¿ø À̽ĿܰúºÐ°ú)
±³À°½Ã°£ 02¿ù 02ÀÏ »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °´ç 15:10~15:25 Therapeutic targeting of the tumor microenvironment in colorectal cancer Á¶¿ë¹ü(»ï¼º¼¿ïº´¿ø ´ëÀåÇ×¹®¿Ü°úºÐ°ú)
±³À°½Ã°£ 02¿ù 02ÀÏ »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °´ç 15:25~15:35 Dynamics of tumor specific-T cells in diverse immune landscape in advanced gastric cancer. ¾È¹Î¾Ö(»ï¼º¼¿ïº´¿ø Çõ½Å¹Ì·¡ÀǷῬ±¸¼¾ÅÍ)
Åä·Ð 02¿ù 02ÀÏ »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °´ç 15:35~15:45 Panel discussion for Collaborative Work ( )
±âŸ 02¿ù 02ÀÏ »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °´ç 15:45~15:50 Closing Remark ÀÌ¿ì¿ë( )